See below for details of all PrecisionLife news, events and media activity as well as links to Disease Studies, research, and publications.
PrecisionLife brings new insight into chronic disease biology through its unique patented combinatorial analytics platform.
23/02/21Digital Medicine and Preventative Healthcare Precision Medicine vs Wearable – Online Event
13/02/21Oxford, UK – PrecisionLife CEO Dr Steve Gardner will be chairing a discussion at this event, organised by One…
27/01/21Oxford, UK – PrecisionLife will be attending this webinar, organised by One Nucleus, and an opportunity to hear from…
27/01/21Oxford, UK – We’ll be attending the Festival of Genomics on Jan 26-29 as the genomics and biodata ecosystems…
26/01/21Oxford, UK – PrecisionLife CEO Dr Steve Gardner chaired a fantastic panel session at Genesis2020 this week organised by…
10/12/20Oxford, UK – We’ll be at BioIntegrates on Nov 16th, a digital event focused on biotech, startups and emerging…
16/11/20Oxford, UK – PrecisionLife is part of a new £5.3m EU Horizon 2020 project that aims to develop precision…
3/02/21Oxford, UK – PrecisionLife is now a member of Genomics England’s Discovery Forum, a network of organisations focused on…
2/11/20Oxford, UK – PrecisionLife has been identified as a leader in the ongoing fight against COVID-19 by Barclays Private…
30/10/20Oxford, UK – We’ll be at LSci Nation’s 4D Meets AI partnering conference this week where we’ll be leading…
17/09/20Oxford, UK – PrecisionLife CEO Dr Steve Gardner will be presenting at MedInvest’s virtual AI, Big Data, and Digital…
10/09/20Oxford, UK – We’re supporting the Startup Terrace Global Hack 2020 – one of Taiwan’s truly international startup events…
9/09/20We built combinatorial risk scores that predict which type of complications a type-II diabetes patient is likely to experience.
8/01/21We stratified a schizophrenia patient population to identify disease sub-groups and new targets for treatment responsive and resistant groups.
10/12/20We revealed clear genetic differences between T2 / non-T2 asthma patients, leading to stratification biomarkers and novel, validated targets for non-T2 asthma.
10/12/20We found 33 novel genes that were strongly associated with ALS and have selected 10 targets of significant interest for drug discovery screening.
9/12/20Oxford, UK – PrecisionLife has appointed Simon Beaulah as SVP of Healthcare and Head of US Operations. Simon’s appointment…
9/09/20